Track Alzamend Neuro Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Alzamend Neuro Inc. Common Stock ALZN · Stock Open Alzamend Neuro Inc. Common Stock in new tab

1.21 USD
Add to portfolio
EPS
-3.67
P/B
1.99
ROE
-249.97
Beta
0.17
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateJuly 28, 2026
EPS-3.67
Book Value0.57
Price to Book1.99
% Insiders0.530%
Estimates
Forward P/E-0.44
Forward EPS-2.60

DCF Valuation

Tweak assumptions to recompute fair value for Alzamend Neuro Inc. Common Stock (ALZN)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Alzamend Neuro Inc. Common Stock Logo Alzamend Neuro Inc. Common Stock Analysis (ALZN)

United States Health Care Official Website Stock

Is Alzamend Neuro Inc. Common Stock a good investment? Alzamend Neuro Inc. Common Stock (ALZN) is currently trading at 1.21 USD.

Earnings Schedule: Alzamend Neuro Inc. Common Stock is expected to release its next earnings report on July 28, 2026. The market consensus estimate for Forward EPS is -2.60.

Investor FAQ

Does Alzamend Neuro Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Alzamend Neuro Inc. Common Stock?

Alzamend Neuro Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 28, 2026. The company currently has a trailing EPS of -3.67.

Company Profile

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Exchange Ticker
NMS (United States) ALZN
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 31, 2023 0.070000
July 16, 2024 0.100000
May 12, 2025 0.110000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Oct. 31, 2023 0.070000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion